BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Free Report)’s share price traded up 34.8% on Thursday . The stock traded as high as $0.12 and last traded at $0.11. 57,200 shares changed hands during mid-day trading, an increase of 173% from the average session volume of 20,967 shares. The stock had previously closed at $0.08.
BetterLife Pharma Price Performance
The stock has a market capitalization of $14.65 million, a P/E ratio of -3.77 and a beta of 1.38. The company has a fifty day moving average of $0.08 and a two-hundred day moving average of $0.09.
BetterLife Pharma Company Profile
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.
Recommended Stories
- Five stocks we like better than BetterLife Pharma
- What Are Growth Stocks and Investing in Them
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Investing in Commodities: What Are They? How to Invest in Them
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Insider Trades May Not Tell You What You Think
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
